Inxight Drugs

U.S. Department of Health & Human Services Divider Arrow

National Institutes of Health Divider Arrow

NCATS

Return Home Inxight Drugs

Home
Browse Drugs
Search
- Structure Search
- Sequence Search
Downloads
About

Show Filters

Hide Filters

Development Status

Other

1

Possibly Marketed Outside US

1

All Match

Any Match

Exclude Selected

Exclude Selected

Approval Year

2009

1

Unknown

1

All Match

Any Match

Exclude Selected

Exclude Selected

Substance Class

Concept

1

Protein

1

All Match

Any Match

Exclude Selected

Exclude Selected

Code System

CAS

2

NDF-RT

2

ChEMBL

1

DRUG BANK

1

EMA ASSESSMENT REPORTS

1

All Match

Any Match

Exclude Selected

Exclude Selected

Substance Form

Principal Form

1

All Match

Any Match

Exclude Selected

Exclude Selected

Search results for "Established Pharmacologic Class [EPC]|Recombinant Antithrombin [EPC]" in comments (approximate match)

Showing 1 - 2 of 2 results

First page disabled
Previous page disabled
1
Next page disabled
Next page disabled

ANTITHROMBIN ALFA

AWV6I5L6H2

Subunit 1 (432) Similarity Search

Export Data
Sequence Search

Subunit 1 (432) Similarity Search

Status:

Possibly Marketed Outside US

First approved in 2009

Class:

PROTEIN

ANTITHROMBIN (RECOMBINANT)

AWV6I5L6H2

Status:

Other

Class:

CONCEPT

HHS VULNERABILITY DISCLOSURE

For language access assistance, contact the NCATS Public Information Officer

National Center for Advancing Translational Sciences (NCATS),
6701 Democracy Boulevard, Bethesda MD 20892-4874 • 301-594-8966


			version 1.1